Harvett,
I can't comment on the older stuff
However of the recent stuff, they are pretty much on schedule for delivery of the product within the timeframes given several months ago.
The new test only takes 3 minutes & is testing for several different drugs all at the same time
With a market cap now of only A$3.5M I shouldn't take to much in the way of sales to boost the bank balance & the share price.
The dual stick test will allow them to cover many more drugs all at once, thus giving them a superior product.
Even I your only making a gross profit of $0.30 a test, it will soon add up because the company is so small.
The stock seems to be attracting interest all of a sudden, which kind of tells its own story - people must be seeing the tangible progress made to date.
LOTM
- Forums
- ASX - By Stock
- SBN
- Ann: Initial Oraline Product Run Completed
Ann: Initial Oraline Product Run Completed , page-25
-
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online